Alice Lallo

839 total citations
10 papers, 489 citations indexed

About

Alice Lallo is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Alice Lallo has authored 10 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Alice Lallo's work include Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Alice Lallo is often cited by papers focused on Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Alice Lallo collaborates with scholars based in United Kingdom, Italy and United States. Alice Lallo's co-authors include Caroline Dive, Fiona Blackhall, Kristopher K. Frese, Federica Di Nicolantonio, Sandra Misale, Alberto Bardelli, Simona Lamba, Mariangela Russo, Sebastijan Hobor and Andrea Sartore‐Bianchi and has published in prestigious journals such as Nature Communications, Science Translational Medicine and British Journal of Pharmacology.

In The Last Decade

Alice Lallo

10 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice Lallo United Kingdom 8 348 215 200 133 82 10 489
Andrea Pretta Italy 12 272 0.8× 182 0.8× 139 0.7× 102 0.8× 59 0.7× 47 478
Kevin S. Quackenbush United States 12 219 0.6× 228 1.1× 112 0.6× 71 0.5× 47 0.6× 17 423
Pina Ziranu Italy 12 251 0.7× 200 0.9× 143 0.7× 116 0.9× 71 0.9× 39 482
Gabriele Picco Italy 9 213 0.6× 364 1.7× 168 0.8× 59 0.4× 99 1.2× 16 563
Jugang Wu China 16 197 0.6× 237 1.1× 99 0.5× 156 1.2× 41 0.5× 30 518
Tianqing Chu China 12 317 0.9× 227 1.1× 163 0.8× 277 2.1× 46 0.6× 46 606
Silvia Paola Corona Italy 13 391 1.1× 230 1.1× 152 0.8× 357 2.7× 54 0.7× 43 689
Elisa Caiola Italy 15 227 0.7× 450 2.1× 208 1.0× 164 1.2× 78 1.0× 33 621
Jianling Zou China 14 243 0.7× 200 0.9× 122 0.6× 119 0.9× 52 0.6× 18 467
Inna Khodos United States 9 364 1.0× 360 1.7× 106 0.5× 198 1.5× 56 0.7× 17 614

Countries citing papers authored by Alice Lallo

Since Specialization
Citations

This map shows the geographic impact of Alice Lallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Lallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Lallo more than expected).

Fields of papers citing papers by Alice Lallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Lallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Lallo. The network helps show where Alice Lallo may publish in the future.

Co-authorship network of co-authors of Alice Lallo

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Lallo. A scholar is included among the top collaborators of Alice Lallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Lallo. Alice Lallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Revill, Mitchell, Alice Lallo, Melanie Galvin, et al.. (2021). Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer. Nature Communications. 12(1). 6652–6652. 16 indexed citations
2.
Lallo, Alice, Sakshi Gulati, Garima Khandelwal, et al.. (2018). Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics. British Journal of Pharmacology. 176(3). 436–450. 32 indexed citations
3.
Lallo, Alice, et al.. (2017). Circulating tumor cells and CDX models as a tool for preclinical drug development. Translational Lung Cancer Research. 6(4). 397–408. 65 indexed citations
4.
Foy, Victoria, Katie Baker, Fábio Gomes, et al.. (2017). Targeting DNA damage in SCLC. Lung Cancer. 114. 12–22. 38 indexed citations
5.
Galvin, Melanie, Alice Lallo, Cassandra L. Hodgkinson, et al.. (2016). Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC. Molecular Cancer Therapeutics. 15(6). 1248–1260. 26 indexed citations
6.
Lallo, Alice, et al.. (2016). Ex vivo culture of circulating tumour cell derived explants to facilitate rapid therapy testing in small cell lung cancer. European Journal of Cancer. 61. S120–S120. 1 indexed citations
7.
Misale, Sandra, Ivana Božić, Jingshan Tong, et al.. (2015). Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers. Nature Communications. 6(1). 8305–8305. 91 indexed citations
8.
Misale, Sandra, Sabrina Arena, Simona Lamba, et al.. (2014). Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer. Science Translational Medicine. 6(224). 224ra26–224ra26. 195 indexed citations
9.
Misale, Sandra, Sabrina Arena, Simona Lamba, et al.. (2013). Abstract C94: Heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer are sensitive to concomitant inhibition of EGFR and MEK.. Molecular Cancer Therapeutics. 12(11_Supplement). C94–C94. 1 indexed citations
10.
Gupta, E, Feijun Luo, Alice Lallo, et al.. (2000). The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s).. PubMed. 20(2A). 1013–6. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026